These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25080432)

  • 1. Perioperative management of diabetic patients: new controversies.
    Aldam P; Levy N; Hall GM
    Br J Anaesth; 2014 Dec; 113(6):906-9. PubMed ID: 25080432
    [No Abstract]   [Full Text] [Related]  

  • 2. [Early insulin treatment in type 2 diabetes--yes].
    Schumm-Draeger PM
    Dtsch Med Wochenschr; 2013 May; 138(18):956. PubMed ID: 23613375
    [No Abstract]   [Full Text] [Related]  

  • 3. HbA(1c) targets for type 2 diabetes: how many, …how far!
    Giugliano D; Ceriello A; Esposito K
    Diabetes Res Clin Pract; 2012 Jun; 96(3):414-5. PubMed ID: 21963106
    [No Abstract]   [Full Text] [Related]  

  • 4. What is the best approach to glycaemic control in patients with type 2 diabetes?
    Garber AJ
    Diabetes Obes Metab; 2015 Feb; 17(2):105-6. PubMed ID: 25359422
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diabetic complications: good metabolic control protects].
    MMW Fortschr Med; 2011 Apr; 153(15):44-5. PubMed ID: 21667560
    [No Abstract]   [Full Text] [Related]  

  • 6. Intensifying insulin therapy with insulin analog premixes: transitioning from basal insulin in type 2 diabetes.
    Shanik MH
    Diabetes Technol Ther; 2012 Jun; 14(6):533-9. PubMed ID: 22364142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["Very good metabolic control by early insulin administration"].
    Schumm-Draeger PM
    MMW Fortschr Med; 2012 Jun; 154(12):25. PubMed ID: 22880291
    [No Abstract]   [Full Text] [Related]  

  • 8. Intensified glucose control in type 2 diabetes--whose agenda?
    Yudkin JS; Richter B; Gale EA
    Lancet; 2011 Apr; 377(9773):1220-2. PubMed ID: 21093903
    [No Abstract]   [Full Text] [Related]  

  • 9. One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target.
    Rosenstock J; Rodbard HW; Bain SC; D'Alessio D; Seufert J; Thomsen AB; Svendsen CB; DeVries JH;
    J Diabetes Complications; 2013; 27(5):492-500. PubMed ID: 23746555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-long-acting insulins for a lifestyle-related pandemic.
    Kudva YC; Basu A
    Lancet; 2011 Mar; 377(9769):880-1. PubMed ID: 21396704
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial.
    Tinahones FJ; Gross JL; Onaca A; Cleall S; Rodríguez A
    Diabetes Obes Metab; 2014 Oct; 16(10):963-70. PubMed ID: 24725616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [When tablets are no longer enough. Which insulin for type 2 diabetic patients?].
    MMW Fortschr Med; 2002 Sep; 144(38):58. PubMed ID: 12395711
    [No Abstract]   [Full Text] [Related]  

  • 13. Summaries for patients. Comparison of two types of insulin added to diabetes pills in poorly controlled type 2 diabetes.
    Ann Intern Med; 2008 Oct; 149(8):I-46. PubMed ID: 18936498
    [No Abstract]   [Full Text] [Related]  

  • 14. Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes.
    Meneghini L; Kesavadev J; Demissie M; Nazeri A; Hollander P
    Diabetes Obes Metab; 2013 Aug; 15(8):729-36. PubMed ID: 23421331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin therapy in type 2 diabetes].
    Hummel M
    MMW Fortschr Med; 2011 Jun; 153(23):56-9, 61; quiz 62. PubMed ID: 21688497
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin glargine. The most studied basal insulin].
    Walter M
    MMW Fortschr Med; 2013 Nov; 155(19):70-1. PubMed ID: 24475676
    [No Abstract]   [Full Text] [Related]  

  • 17. [Basal insulin and GLP-1 agonist potentiate each other (interview by Dr. med Dirk Einecke)].
    Einecke D
    MMW Fortschr Med; 2012 Jun; 154(12):28. PubMed ID: 22880293
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-acting insulins in the treatment of type 2 diabetes: a hard choice].
    Liebl A
    MMW Fortschr Med; 2015 Apr; 157(7):65-8. PubMed ID: 26012462
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rapid disease progression, early insulin requirement].
    Einecke D
    MMW Fortschr Med; 2012 Jun; 154(12):26. PubMed ID: 22880292
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intensified insulin therapy. Is there an alternative to BE count?].
    MMW Fortschr Med; 2006 Sep; 148(37):21. PubMed ID: 17036898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.